Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches have already been developed to curb the detrimental effects of autoimmune diseases, and the market continues to flourish. In fact, by 2025 this market is estimated to exceed a global value of $150 billion.
At Inova, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO), in partnership with Evaluate, are organizing this Immunology Virtual Partnering Event. Through online one-to-one meetings taking place 9-12 March, researchers, biotechs and biopharmaceutical companies will discuss the latest research from immunology congresses, pitch ideas and partner to prioritize the most promising research efforts.
This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.
EuropaBio Members can benefit from a 15% discount. Please liaise with Martina Cilia for further details.
+33 4 78 27 95 02